VEGFA and Atrophy: Because a continuation of the anti-VEGF treatment was not a significant factor affecting the expansion of RPE atrophy, the factors that may cause the expansion of RPE atrophy, including the atrophic processes, have not been excluded even if anti-VEGF drug exposure was not present after the treatment was suspended.